Showing results (11-20 of 1,310) with videos related to
Sort By:
Pageof 131
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1983
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesisS Wilson, A Vincent, J Newsom-DavisLancet (London, England)|January 18, 1986
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entityS Mossman, A Vincent, J Newsom-DavisEuropean Journal of Biochemistry|August 1, 1985
Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding siteP Whiting, A Vincent, J Newsom-DavisTrends in Neurosciences|December 1, 1989
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorderA Vincent, B Lang, J Newsom-DavisAutoimmunity|January 1, 1988
Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myastheniaF Heidenreich, A Vincent, J Newsom-DavisJournal of Neurology, Neurosurgery, and Psychiatry|May 1, 1983
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradationS Wilson, A Vincent, J Newsom-DavisJournal of Neuroimmunology|August 1, 1988
Immunological and pharmacological heterogeneity of alpha-bungarotoxin binding sites extracted from TE671 cellsR Walker, A Vincent, J Newsom-DavisJournal of Neuroimmunology|August 1, 1983
Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclassP J Whiting, A Vincent, J Newsom-DavisJournal of Neurology, Neurosurgery, and Psychiatry|June 1, 1981
Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergyC J Hawkey, J Newsom-Davis, A VincentNeurology|May 1, 1986
Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatmentP J Whiting, A Vincent, J Newsom-DavisPageof 131